Recent Updates
Recently added Catalysts
ELDN Positive Sentiment

Eledon’s Antibody Aids First Gene-Edited, Pig-to-Human Kidney Transplant

Key Takeaway: Eledon has achieved a milestone by utilizing its antibody in the first successful pig-to-human kidney transplant, aided by gene-editing techniques. This pioneering procedure is expected to transform organ transplantation, offering new hope for patients in need of kidney transplants. The advancement highlights the potential of combining biotechnology with organ donation.
Price reaction · baseline $1.66 (2024-04-11 close) · hit after-hours · 5 other ELDN headline(s) in the window, move may be shared
day 0 close · peak
+1.8%

Market Sentiment Analysis

POSITIVE FACTORS

  • Eledon’s antibody successfully aids in a groundbreaking pig-to-human kidney transplant.
  • This advancement represents a significant step forward in organ transplantation.
  • The procedure showcases innovative gene-editing technology.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+90%
120-day peak, hindsight
Typical move
6.5%
average across 7 past catalysts
Cash runway
~11 mo
Medium dilution risk
Lead asset
AT-1501
Phase 2 · Kidney Transplant Rejection

Full Press Release Details

Transforming Lives. One Organ at a Time.
• Overview Focus Patient Stories Clinical Trials In The News
• Science Mechanism of Action Pipeline Publications & Presentations In The News
• Team Overview Leadership Board of Directors
• Investors Overview News & Events Press Releases Events Publications & Presentations Corporate Governance Governance Overview Committee Composition Ethics Hotline Financials SEC Filings Stock Information Stock Quote & Chart Analyst Coverage Resources Investor FAQs Email Alerts Contact IR
• Culture/Careers Culture Careers
• Contact
• Focus
• Patient Stories
• Clinical Trials
• In The News
• Mechanism of Action
• Pipeline
• Publications & Presentations
• In The News
• Overview
• Leadership
• Board of Directors
• Overview
• News & Events Press Releases Events Publications & Presentations
• Corporate Governance Governance Overview Committee Composition Ethics Hotline
• Financials SEC Filings
• Stock Information Stock Quote & Chart Analyst Coverage
• Resources Investor FAQs Email Alerts Contact IR
• Press Releases
• Events
• Publications & Presentations
• Governance Overview
• Committee Composition
• Ethics Hotline
• SEC Filings
• Stock Quote & Chart
• Analyst Coverage
• Investor FAQs
• Email Alerts
• Contact IR
• Culture
• Careers
• Privacy Overview
• Necessary
• Analytics
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.

Frequently Asked Questions

What milestone did Eledon achieve?

Eledon successfully aided in the first pig-to-human kidney transplant.

How does Eledon's antibody contribute to transplants?

Eledon's antibody plays a crucial role in facilitating the pig-to-human kidney transplant.

What technology was used in the transplant?

The procedure utilized innovative gene-editing technology.

What is the significance of this transplant?

This advancement represents a major step forward in organ transplantation.

Last updated: Apr 11, 2024